{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-fibrotic", "Chronic pancreatitis", "Curcumin", "Emodin", "Green tea catechin", "Pancreatic cancer", "Pancreatic stellate cells", "Phytochemicals", "Resverastrol", "Rhein"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32140388", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1016/j.apsb.2019.11.008"], "Journal": {"ISSN": "2211-3835", "JournalIssue": {"Volume": "10", "Issue": "3", "PubDate": {"Year": "2020", "Month": "Mar"}}, "Title": "Acta pharmaceutica Sinica. B", "ISOAbbreviation": "Acta Pharm Sin B"}, "ArticleTitle": "Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer.", "Pagination": {"StartPage": "399", "EndPage": "413", "MedlinePgn": "399-413"}, "Abstract": {"AbstractText": ["Activated pancreatic stellate cells (PSCs) have been widely accepted as a key precursor of excessive pancreatic fibrosis, which is a crucial hallmark of chronic pancreatitis (CP) and its formidable associated disease, pancreatic cancer (PC). Hence, anti-fibrotic therapy has been identified as a novel therapeutic strategy for treating CP and PC by targeting PSCs. Most of the anti-fibrotic agents have been limited to phase I/II clinical trials involving vitamin analogs, which are abundant in medicinal plants and have proved to be promising for clinical application. The use of phytomedicines, as new anti-fibrotic agents, has been applied to a variety of complementary and alternative approaches. The aim of this review was to present a focused update on the selective new potential anti-fibrotic agents, including curcumin, resveratrol, rhein, emodin, green tea catechin derivatives, metformin, eruberin A, and ellagic acid, in combating PSC in CP and PC models. It aimed to describe the mechanism(s) of the phytochemicals used, either alone or in combination, and the associated molecular targets. Most of them were tested in PC models with similar mechanism of actions, and curcumin was tested intensively. Future research may explore the issues of bioavailability, drug design, and nano-formulation, in order to achieve successful clinical outcomes with promising activity and tolerability."], "CopyrightInformation": "\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Ageing and Age-Associated Disorders Research Group, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia."}], "LastName": "Ramakrishnan", "ForeName": "Puvanesswaray", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia."}], "LastName": "Loh", "ForeName": "Wei Mee", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Bioprocess Engineering, Universiti Malaysia Perlis, Arau 02600, Malaysia."}, {"Identifier": [], "Affiliation": "Institute of Nano Electronic Engineering, Universiti Malaysia Perlis, Kangar 01000, Malaysia."}], "LastName": "Gopinath", "ForeName": "Subash C B", "Initials": "SCB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UMR 7242, CNRS-University of Strasbourg, Biotechnology and Cell Signaling/Laboratory of Excellence Medalis, Illkirch 67400, France."}], "LastName": "Bonam", "ForeName": "Srinivasa Reddy", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral Biology and Biomedical Sciences, Faculty of Dentistry, MAHSA University, Selangor 42610, Malaysia."}], "LastName": "Fareez", "ForeName": "Ismail M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Science and Therapeutics, Faculty of Medicine and Health Science, Universiti Malaysia Sabah, Kota Kinabalu 88400, Malaysia."}], "LastName": "Mac Guad", "ForeName": "Rhanye", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, University of Malaya, Kuala Lumpur 50603, Malaysia."}], "LastName": "Sim", "ForeName": "Maw Shin", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Bioscience and Nursing, MAHSA University, Selangor 42610, Malaysia."}], "LastName": "Wu", "ForeName": "Yuan Seng", "Initials": "YS"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Acta Pharm Sin B", "NlmUniqueID": "101600560", "ISSNLinking": "2211-3835"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bynigeri R.R., Jakkampudi A., Jangala R., Subramanyam C., Sasikala M., Rao G.V. Pancreatic stellate cell: Pandora's box for pancreatic disease biology. World J Gastroenterol. 2017;23:382\u2013405.", "ArticleIdList": ["PMC5291844", "28210075"]}, {"Citation": "Masamune A., Watanabe T., Kikuta K., Shimosegawa T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol. 2009;7:S48\u2013S54.", "ArticleIdList": ["19896099"]}, {"Citation": "Talukdar R., Tandon R.K. Pancreatic stellate cells: new target in the treatment of chronic pancreatitis. J Gastroenterol Hepatol. 2008;23:34\u201341.", "ArticleIdList": ["17995943"]}, {"Citation": "Dun\u00e9r S., Lopatko Lindman J., Ansari D., Gundewar C., Andersson R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology. 2011;10:673\u2013681.", "ArticleIdList": ["21242706"]}, {"Citation": "Luttenberger T., Schmid-Kotsas A., Menke A., Siech M., Beger H., Adler G. Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest. 2000;80:47\u201355.", "ArticleIdList": ["10653002"]}, {"Citation": "Schneider E., Schmid-Kotsas A., Zhao J., Weidenbach H., Schmid R.M., Menke A. Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol. 2001;281:C532\u2013C543.", "ArticleIdList": ["11443052"]}, {"Citation": "Mews P., Phillips P., Fahmy R., Korsten M., Pirola R., Wilson J. Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut. 2002;50:535\u2013541.", "ArticleIdList": ["PMC1773172", "11889076"]}, {"Citation": "Ohnishi N., Miyata T., Ohnishi H., Yasuda H., Tamada K., Ueda N. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut. 2003;52:1487\u20131493.", "ArticleIdList": ["PMC1773818", "12970143"]}, {"Citation": "Apte M.V., Haber P.S., Darby S.J., Rodgers S.C., McCaughan G.W., Korsten M.A. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut. 1999;44:534\u2013541.", "ArticleIdList": ["PMC1727467", "10075961"]}, {"Citation": "Apte M.V., Phillips P.A., Fahmy R.G., Darby S.J., Rodgers S.C., McCaughan G.W. Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology. 2000;118:780\u2013794.", "ArticleIdList": ["10734030"]}, {"Citation": "Masamune A., Kikuta K., Satoh M., Satoh A., Shimosegawa T. Alcohol activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. J Pharmacol Exp Ther. 2002;302:36\u201342.", "ArticleIdList": ["12065697"]}, {"Citation": "Watanabe S., Nagashio Y., Asaumi H., Nomiyama Y., Taguchi M., Tashiro M. Pressure activates rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1175\u2013G1181.", "ArticleIdList": ["15319186"]}, {"Citation": "Masamune A., Kikuta K., Satoh M., Kume K., Shimosegawa T. Differential roles of signaling pathways for proliferation and migration of rat pancreatic stellate cells. Tohoku J Exp Med. 2003;199:69\u201384.", "ArticleIdList": ["12705352"]}, {"Citation": "Lee A.T., Xu Z., Pothula S.P., Patel M.B., Pirola R.C., Wilson J.S. Alcohol and cigarette smoke components activate human pancreatic stellate cells: implications for the progression of chronic pancreatitis. Alcohol Clin Exp Res. 2015;39:2123\u20132133.", "ArticleIdList": ["26463405"]}, {"Citation": "Kanat O., Ertas H. Shattering the castle walls: anti-stromal therapy for pancreatic cancer. World J Gastrointest Oncol. 2018;10:202\u2013210.", "ArticleIdList": ["PMC6107476", "30147846"]}, {"Citation": "Swayden M., Iovanna J., Soubeyran P. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype. Heliyon. 2018;4 e01055.", "ArticleIdList": ["PMC6299038", "30582059"]}, {"Citation": "Wang C., Liu B., Xu X., Zhuang B., Li H., Yin J. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget. 2016;7:8360\u20138372.", "ArticleIdList": ["PMC4884998", "26840019"]}, {"Citation": "Gunda V., Souchek J., Abrego J., Shukla S.K., Goode G.D., Vernucci E. MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clin Cancer Res. 2017;23:5881\u20135891.", "ArticleIdList": ["PMC5626603", "28720669"]}, {"Citation": "Gunda V., Souchek J., Abrego J., Goode G., Vernucci E., Shukla S.K. Abstract 459: Targeting MUC1 mediated nucleotide metabolism sensitizes pancreatic tumors to radiation therapy. Proceedings: American association for cancer research annual meeting 2017, Washington, DC. Cancer Res. 2017 AM2017\u2013A2459."}, {"Citation": "Mantoni T.S., Lunardi S., Al-Assar O., Masamune A., Brunner T.B. Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res. 2011;71:3453\u20133458.", "ArticleIdList": ["PMC3097171", "21558392"]}, {"Citation": "Bonam S.R., Wu Y.S., Tunki L., Chellian R., Halmuthur M.S.K., Muller S. What has come out from phytomedicines and herbal edibles for the treatment of cancer? ChemMedChem. 2018;13:1854\u20131872.", "ArticleIdList": ["29927521"]}, {"Citation": "Azimi H., Khakshur A.A., Abdollahi M., Rahimi R. Potential New pharmacological agents derived from medicinal plants for the treatment of pancreatic cancer. Pancreas. 2015;44:11\u201315.", "ArticleIdList": ["25493374"]}, {"Citation": "Vuong Q.V., Hirun S., Phillips P.A., Chuen T.L., Bowyer M.C., Goldsmith C.D. Fruit-derived phenolic compounds and pancreatic cancer: perspectives from Australian native fruits. J Ethnopharmacol. 2014;152:227\u2013242.", "ArticleIdList": ["24463158"]}, {"Citation": "Yang T., Liu J., Luo F., Lin Q., Rosol T.J., Deng X. Anticancer properties of Monascus metabolites. Anti Cancer Drugs. 2014;25:735\u2013744.", "ArticleIdList": ["24637578"]}, {"Citation": "Suklabaidya S., Das B., Ali S.A., Jain S., Swaminathan S., Mohanty A.K. Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget. 2016;7:41825.", "ArticleIdList": ["PMC5173099", "27259232"]}, {"Citation": "Xue R., Jia K., Wang J., Yang L., Wang Y., Gao L. A rising star in pancreatic diseases: pancreatic stellate cells. Front Physiol. 2018;9:754.", "ArticleIdList": ["PMC6015921", "29967585"]}, {"Citation": "Lafaro K.J., Melstrom L.G. The paradoxical web of pancreatic cancer tumor microenvironment. Am J Pathol. 2019;189:44\u201357.", "ArticleIdList": ["PMC6315325", "30558722"]}, {"Citation": "Allam A., Thomsen A.R., Gothwal M., Saha D., Maurer J., Brunner T.B. Pancreatic stellate cells in pancreatic cancer: in focus. Pancreatology. 2017;17:514\u2013522.", "ArticleIdList": ["28601475"]}, {"Citation": "Haqq J., Howells L.M., Garcea G., Metcalfe M.S., Steward W.P., Dennison A.R. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Eur J Cancer. 2014;50:2570\u20132582.", "ArticleIdList": ["25091797"]}, {"Citation": "Ben-Harosh Y., Anosov M., Salem H., Yatchenko Y., Birk R. Pancreatic stellate cell activation is regulated by fatty acids and ER stress. Exp Cell Res. 2017;359:76\u201385.", "ArticleIdList": ["28827060"]}, {"Citation": "Pothula S.P., Xu Z., Goldstein D., Pirola R.C., Wilson J.S., Apte M.V. Key role of pancreatic stellate cells in pancreatic cancer. Cancer Lett. 2016;381:194\u2013200.", "ArticleIdList": ["26571462"]}, {"Citation": "Tang D., Wang D., Yuan Z., Xue X., Zhang Y., An Y. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer. 2013;132:993\u20131003.", "ArticleIdList": ["22777597"]}, {"Citation": "Madro A., Celinski K., Slomka M. The role of pancreatic stellate cells and cytokines in the development of chronic pancreatitis. Med Sci Monit. 2004;10:RA166\u2013RA170.", "ArticleIdList": ["15232519"]}, {"Citation": "Wu Y.S., Looi C.Y., Subramaniam K.S., Masamune A., Chung I. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. Oncotarget. 2016;7:36719.", "ArticleIdList": ["PMC5095034", "27167341"]}, {"Citation": "Wu Y.S., Chung I., Wong W.F., Masamune A., Sim M.S., Looi C.Y. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochim Biophys Acta Gen Subj. 2017;1861:296\u2013306.", "ArticleIdList": ["27750041"]}, {"Citation": "Schnittert J., Bansal R., Prakash J. Targeting pancreatic stellate cells in cancer. Trends Cancer. 2019;5:128\u2013142.", "ArticleIdList": ["30755305"]}, {"Citation": "Pang T.C.Y., Wilson J.S., Apte M.V. Pancreatic stellate cells: what's new? Curr Opin Gastroenterol. 2017;33:366\u2013373.", "ArticleIdList": ["28590306"]}, {"Citation": "Kuhlmann L., Olesen S.S., Olesen A.E., Arendt-Nielsen L., Drewes A.M. Mechanism-based pain management in chronic pancreatitis\u2014is it time for a paradigm shift? Expert Rev Clin Pharmacol. 2019;12:249\u2013258.", "ArticleIdList": ["30664364"]}, {"Citation": "Chand S.K., Pendharkar S.A., Bharmal S.H., Bartlett A.S., Pandol S.J., Petrov M.S. Frequency and risk factors for liver disease following pancreatitis: a population-based cohort study. Dig Liver Dis. 2019;51:551\u2013558.", "ArticleIdList": ["PMC6785026", "30522894"]}, {"Citation": "Narkhede R.A., Desai G.S., Prasad P.P., Wagle P.K. Diagnosis and management of pancreatic adenocarcinoma in the background of chronic pancreatitis: core issues. Dig Dis. 2019;37:315\u2013324.", "ArticleIdList": ["30699408"]}, {"Citation": "Rawla P., Sunkara T., Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10\u201327.", "ArticleIdList": ["PMC6396775", "30834048"]}, {"Citation": "Shimizu K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J Gastroenterol. 2008;43:823\u2013832.", "ArticleIdList": ["19012035"]}, {"Citation": "Zhang L., Li J., Zong L., Chen X., Chen K., Jiang Z. Reactive oxygen species and targeted therapy for pancreatic cancer. Oxid Med Cell Longev. 2016;2016 1616781.", "ArticleIdList": ["PMC4735911", "26881012"]}, {"Citation": "Braganza J.M., Lee S.H., McCloy R.F., McMahon M.J. Chronic pancreatitis. Lancet. 2011;377:1184\u20131197.", "ArticleIdList": ["21397320"]}, {"Citation": "Apte M., Pirola R., Wilson J. The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells. Antioxidants Redox Signal. 2011;15:2711\u20132722.", "ArticleIdList": ["21728885"]}, {"Citation": "Sanabria Mateos R., Conlon K.C. Pancreatic cancer. Surgery. 2016;34:282\u2013291."}, {"Citation": "Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605\u20131617.", "ArticleIdList": ["20427809"]}, {"Citation": "Maisonneuve P. Epidemiology and burden of pancreatic cancer. Presse Med. 2019;48:e113\u2013e123.", "ArticleIdList": ["30878335"]}, {"Citation": "W\u00f6rmann S.M., Diakopoulos K.N., Lesina M., Alg\u00fcl H. The immune network in pancreatic cancer development and progression. Oncogene. 2013;33:2956.", "ArticleIdList": ["23851493"]}, {"Citation": "Kim H.W., Lee J.C., Paik K.H., Kang J., Kim J., Hwang J.H. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern. Medicine (Baltim) 2017;96 e5926.", "ArticleIdList": ["PMC5293435", "28151872"]}, {"Citation": "Whitcomb D., Greer J. Germ-line mutations, pancreatic inflammation, and pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:S29\u2013S34.", "ArticleIdList": ["19896094"]}, {"Citation": "Muniraj T., Jamidar P.A., Aslanian H.R. Pancreatic cancer: a comprehensive review and update. Dis Mon. 2013;59:368\u2013402.", "ArticleIdList": ["24183261"]}, {"Citation": "Salvia R., Casciani F., Sereni E., Bassi C. Pancreatic cancer\u2014what\u2019s next? Presse Med. 2019;48:e187\u2013e197.", "ArticleIdList": ["30878338"]}, {"Citation": "Xie D., Xie K. Pancreatic cancer stromal biology and therapy. Genes Dis. 2015;2:133\u2013143.", "ArticleIdList": ["PMC4476547", "26114155"]}, {"Citation": "Liu S.L., Cao S.G., Li Y., Sun B., Chen D., Wang D.S. Pancreatic stellate cells facilitate pancreatic cancer cell viability and invasion. Oncol Lett. 2019;17:2057\u20132062.", "ArticleIdList": ["PMC6341873", "30675272"]}, {"Citation": "Petersen O.W., Nielsen H.L., Gudjonsson T., Villadsen R., Rank F., Niebuhr E. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol. 2003;162:391\u2013402.", "ArticleIdList": ["PMC1851146", "12547698"]}, {"Citation": "Komar H.M., Serpa G., Kerscher C., Schwoegl E., Mace T.A., Jin M. Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in\u00a0vitro and limits caerulein-induced chronic pancreatitis in\u00a0vivo. Sci Rep. 2017;7:1787.", "ArticleIdList": ["PMC5431930", "28496202"]}, {"Citation": "Lin Z., Zheng L.C., Zhang H.J., Tsang S.W., Bian Z.X. Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells. BMC Complement Altern Med. 2015;15:259.", "ArticleIdList": ["PMC4520255", "26223780"]}, {"Citation": "Kocaadam B., Sanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57:2889\u20132895.", "ArticleIdList": ["26528921"]}, {"Citation": "Yang C.L., Liu Y.Y., Ma Y.G., Xue Y.X., Liu D.G., Ren Y. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 2012;7 e37960.", "ArticleIdList": ["PMC3360669", "22662257"]}, {"Citation": "Bharti A.C., Donato N., Singh S., Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003;101:1053\u20131062.", "ArticleIdList": ["12393461"]}, {"Citation": "Shehzad A., Rehman G., Lee Y.S. Curcumin in inflammatory diseases. Biofactors. 2013;39:69\u201377.", "ArticleIdList": ["23281076"]}, {"Citation": "Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173\u2013199.", "ArticleIdList": ["PMC3144156", "20420526"]}, {"Citation": "Zhang D.W., Fu M., Gao S.H., Liu J.L. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013;2013:636053.", "ArticleIdList": ["PMC3857752", "24348712"]}, {"Citation": "Masamune A., Suzuki N., Kikuta K., Satoh M., Satoh K., Shimosegawa T. Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem. 2006;97:1080\u20131093.", "ArticleIdList": ["16294327"]}, {"Citation": "Shehzad A., Ha T., Subhan F., Lee Y.S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur J Nutr. 2011;50:151\u2013161.", "ArticleIdList": ["21442412"]}, {"Citation": "Schwer C.I., Guerrero A.M., Humar M., Roesslein M., Goebel U., Stoll P. Heme oxygenase-1 inhibits the proliferation of pancreatic stellate cells by repression of the extracellular signal-regulated kinase1/2 pathway. J Pharmacol Exp Ther. 2008;327:863\u2013871.", "ArticleIdList": ["18784349"]}, {"Citation": "Gundewar C., Ansari D., Tang L., Wang Y., Liang G., Rosendahl A.H. Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study. Ann Gastroenterol. 2015;28:391\u2013398.", "ArticleIdList": ["PMC4480178", "26129848"]}, {"Citation": "Kanai M., Yoshimura K., Asada M., Imaizumi A., Suzuki C., Matsumoto S. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant\u00a0pancreatic cancer. Cancer Chemother Pharmacol. 2011;68:157\u2013164.", "ArticleIdList": ["20859741"]}, {"Citation": "Shehzad A., Qureshi M., Anwar M.N., Lee Y.S. Multifunctional curcumin mediate multitherapeutic effects. J Food Sci. 2017;82:2006\u20132015.", "ArticleIdList": ["28771714"]}, {"Citation": "Durgaprasad S., Pai C.G., Vasanthkumar Alvres JF., Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res. 2005;122:315\u2013318.", "ArticleIdList": ["16394323"]}, {"Citation": "Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as \u201cCurecumin\u201d: from kitchen to clinic. Biochem Pharmacol. 2008;75:787\u2013809.", "ArticleIdList": ["17900536"]}, {"Citation": "Sun H., Luo G., Chen D., Xiang Z. A comprehensive and system review for the pharmacological mechanism of action of rhein, an active anthraquinone ingredient. Front Pharmacol. 2016;7:247.", "ArticleIdList": ["PMC4987408", "27582705"]}, {"Citation": "Wang J., Zhao H., Kong W., Jin C., Zhao Y., Qu Y. Microcalorimetric assay on the antimicrobial property of five hydroxyanthraquinone derivatives in rhubarb (Rheum palmatum L.) to Bifidobacterium adolescentis. Phytomedicine. 2010;17:684\u2013689.", "ArticleIdList": ["19962872"]}, {"Citation": "Cong X.D., Ding M.J., Dai D.Z., Wu Y., Zhang Y., Dai Y. ER stress, p66shc, and p-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats. Inflammation. 2012;35:1031\u20131040.", "ArticleIdList": ["22095404"]}, {"Citation": "Fernand V.E., Losso J.N., Truax R.E., Villar E.E., Bwambok D.K., Fakayode S.O. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in\u00a0vitro. Chem Biol Interact. 2011;192:220\u2013232.", "ArticleIdList": ["21457705"]}, {"Citation": "He Z.H., Zhou R., He M.F., Lau C.B., Yue G.G., Ge W. Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine. 2011;18:470\u2013478.", "ArticleIdList": ["21112197"]}, {"Citation": "Chang C.Y., Chan H.L., Lin H.Y., Way T.D., Kao M.C., Song M.Z. Rhein induces apoptosis in human breast cancer cells. Evid Based Complement Alternat Med. 2012;2012 952504.", "ArticleIdList": ["PMC3189565", "22007260"]}, {"Citation": "Yang X., Sun G., Yang C., Wang B. Novel rhein analogues as potential anticancer agents. ChemMedChem. 2011;6:2294\u20132301.", "ArticleIdList": ["21954017"]}, {"Citation": "Hu L., Cui R., Liu H., Wang F. Emodin and rhein decrease levels of hypoxia-inducible factor-1alpha in human pancreatic cancer cells and attenuate cancer cachexia in athymic mice carrying these cells. Oncotarget. 2017;8:88008\u201388020.", "ArticleIdList": ["PMC5675689", "29152137"]}, {"Citation": "Tsang S.W., Zhang H., Lin C., Xiao H., Wong M., Shang H. Rhein, a natural anthraquinone derivative, attenuates the activation of pancreatic stellate cells and ameliorates pancreatic fibrosis in mice\u00a0with experimental chronic pancreatitis. PLoS One. 2013;8 e82201.", "ArticleIdList": ["PMC3849497", "24312641"]}, {"Citation": "Tsang S.W., Bian Z.X. Anti-fibrotic and anti-tumorigenic effects of rhein, a natural anthraquinone derivative, in mammalian stellate and carcinoma cells. Phytother Res. 2015;29:407\u2013414.", "ArticleIdList": ["25510440"]}, {"Citation": "Yang L., Lin S., Kang Y., Xiang Y., Xu L., Li J. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway. J Exp Clin Cancer Res. 2019;38:31.", "ArticleIdList": ["PMC6343257", "30674340"]}, {"Citation": "Chacko S.M., Thambi P.T., Kuttan R., Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5:13.", "ArticleIdList": ["PMC2855614", "20370896"]}, {"Citation": "Hosseini A., Ghorbani A. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed. 2015;5:84\u201397.", "ArticleIdList": ["PMC4418057", "25949949"]}, {"Citation": "Lee L.S., Kim S.H., Kim Y.B., Kim Y.C. Quantitative analysis of major constituents in green tea with different plucking periods and their antioxidant activity. Molecules. 2014;19:9173\u20139186.", "ArticleIdList": ["PMC6271668", "24988187"]}, {"Citation": "Masamune A., Kikuta K., Satoh M., Suzuki N., Shimosegawa T. Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol. 2005;11:3368\u20133374.", "ArticleIdList": ["PMC4315990", "15948241"]}, {"Citation": "Asaumi H., Watanabe S., Taguchi M., Tashiro M., Nagashio Y., Nomiyama Y. Green tea polyphenol (\u2013)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Investig. 2006;36:113\u2013122.", "ArticleIdList": ["16436093"]}, {"Citation": "Shen K., Feng X., Su R., Xie H., Zhou L., Zheng S. Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation. PLoS One. 2015;10 e0126278.", "ArticleIdList": ["PMC4425400", "25955525"]}, {"Citation": "Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783\u20132840.", "ArticleIdList": ["15517885"]}, {"Citation": "Hasan M., Bae H. An overview of stress-induced resveratrol synthesis in grapes: perspectives for resveratrol-enriched grape products. Molecules. 2017;22 E294.", "ArticleIdList": ["PMC6155908", "28216605"]}, {"Citation": "Cho S., Namkoong K., Shin M., Park J., Yang E., Ihm J. Cardiovascular protective effects and clinical applications of resveratrol. J Med Food. 2017;20:323\u2013334.", "ArticleIdList": ["28346848"]}, {"Citation": "Bhatt J.K., Thomas S., Nanjan M.J. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012;32:537\u2013541.", "ArticleIdList": ["22901562"]}, {"Citation": "Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation. 2017;14:1.", "ArticleIdList": ["PMC5234138", "28086917"]}, {"Citation": "Turner R.S., Thomas R.G., Craft S., van Dyck C.H., Mintzer J., Reynolds B.A. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology. 2015;85:1383\u20131391.", "ArticleIdList": ["PMC4626244", "26362286"]}, {"Citation": "Howells L.M., Berry D.P., Elliott P.J., Jacobson E.W., Hoffmann E., Hegarty B. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2014safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res. 2011;4:1419\u20131425.", "ArticleIdList": ["PMC3173869", "21680702"]}, {"Citation": "Kulkarni S.S., Canto C. The molecular targets of resveratrol. Biochim Biophys Acta. 2015;1852:1114\u20131123.", "ArticleIdList": ["25315298"]}, {"Citation": "Patel K.R., Brown V.A., Jones D.J., Britton R.G., Hemingway D., Miller A.S. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70:7392\u20137399.", "ArticleIdList": ["PMC2948608", "20841478"]}, {"Citation": "Zhou J.H., Cheng H.Y., Yu Z.Q., He D.W., Pan Z., Yang D.T. Resveratrol induces apoptosis in pancreatic cancer cells. Chin Med J. 2011;124:1695\u20131699.", "ArticleIdList": ["21740780"]}, {"Citation": "Cheng L., Yan B., Chen K., Jiang Z., Zhou C., Cao J. Resveratrol-induced downregulation of NAF-1 enhances the sensitivity of pancreatic cancer cells to gemcitabine via the ROS/Nrf2 signaling pathways. Oxid Med Cell Longev. 2018;2018 9482018.", "ArticleIdList": ["PMC5885341", "29765509"]}, {"Citation": "Zhou C., Qian W., Ma J., Cheng L., Jiang Z., Yan B. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2019;52 e12514.", "ArticleIdList": ["PMC6430460", "30341797"]}, {"Citation": "Yang L., Yang L., Tian W., Li J., Liu J., Zhu M. Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol. 2014;140:749\u2013755.", "ArticleIdList": ["24604347"]}, {"Citation": "Yan B., Cheng L., Jiang Z., Chen K., Zhou C., Sun L. Resveratrol inhibits ROS-promoted activation and glycolysis of pancreatic stellate cells via suppression of miR-21. Oxid Med Cell Longev. 2018;2018 1346958.", "ArticleIdList": ["PMC5944235", "29854071"]}, {"Citation": "Gaman L., Dragos D., Vlad A., Robu G.C., Radoi M.P., Stroica L. Phytoceuticals in acute pancreatitis: targeting the balance between apoptosis and necrosis. Evid Based Complement Alternat Med. 2018;2018 5264592.", "ArticleIdList": ["PMC5857302", "29686719"]}, {"Citation": "Guo H.C., Bu H.Q., Luo J., Wei W.T., Liu D.L., Chen H. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in\u00a0vivo via inhibition of inhibitors of apoptosis. Int J Oncol. 2012;40:1849\u20131857.", "ArticleIdList": ["22378302"]}, {"Citation": "Han J.W., Shim D.W., Shin W.Y., Heo K.H., Kwak S.B., Sim E.J. Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation. Int J Mol Sci. 2015;16:8102\u20138109.", "ArticleIdList": ["PMC4425069", "25867480"]}, {"Citation": "Tzeng T.F., Lu H.J., Liou S.S., Chang C.J., Liu I.M. Emodin, a naturally occurring anthraquinone derivative, ameliorates dyslipidemia by activating AMP-activated protein kinase in high-fat-diet-fed rats. Evid Based Complement Alternat Med. 2012;2012 781812.", "ArticleIdList": ["PMC3357974", "22649478"]}, {"Citation": "Liu A., Chen H., Tong H., Ye S., Qiu M., Wang Z. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-kappaB. Mol Med Rep. 2011;4:221\u2013227.", "ArticleIdList": ["21468555"]}, {"Citation": "Saldanha E., Joseph N., Ravi R., Kumar A., Shetty V., Fayad R. Polyphenols in the prevention of acute pancreatitis: preclinical observations. In: Watson R.R., Preedy V.R., Zibadi S., editors. Polyphenols in human health and disease. Academic Press; San Diago, CA: 2014. pp. 427\u2013433."}, {"Citation": "Kang I., Buckner T., Shay N.F., Gu L., Chung S. Improvements in metabolic health with consumption of ellagic acid and subsequent conversion into urolithins: evidence and mechanisms. Adv Nutr. 2016;7:961\u2013972.", "ArticleIdList": ["PMC5015040", "27633111"]}, {"Citation": "Polce S.A., Burke C., Franca L.M., Kramer B., de Andrade Paes A.M., Carrillo-Sepulveda M.A. Ellagic acid alleviates hepatic oxidative stress and insulin resistance in diabetic female rats. Nutrients. 2018;10 E531.", "ArticleIdList": ["PMC5986411", "29693586"]}, {"Citation": "Ceci C., Tentori L., Atzori M.G., Lacal P.M., Bonanno E., Scimeca M. Ellagic acid inhibits bladder cancer invasiveness and in\u00a0vivo tumor growth. Nutrients. 2016;8 E744.", "ArticleIdList": ["PMC5133127", "27879653"]}, {"Citation": "Edderkaoui M., Lugea A., Hui H., Eibl G., Lu Q.Y., Moro A. Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells. Nutr Cancer. 2013;65:1232\u20131244.", "ArticleIdList": ["PMC3909533", "24127740"]}, {"Citation": "Suzuki N., Masamune A., Kikuta K., Watanabe T., Satoh K., Shimosegawa T. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats. Dig Dis Sci. 2009;54:802\u2013810.", "ArticleIdList": ["18651219"]}, {"Citation": "Masamune A., Satoh M., Kikuta K., Suzuki N., Satoh K., Shimosegawa T. Ellagic acid blocks activation of pancreatic stellate cells. Biochem Pharmacol. 2005;70:869\u2013878.", "ArticleIdList": ["16023081"]}, {"Citation": "Huang Y., Lu J., Gao X., Li J., Zhao W., Sun M. PEG-derivatized embelin as a dual functional carrier for the delivery of paclitaxel. Bioconjug Chem. 2012;23:1443\u20131451.", "ArticleIdList": ["PMC3399921", "22681537"]}, {"Citation": "Kim S.W., Kim S.M., Bae H., Nam D., Lee J.H., Lee S.G. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades. The Prostate. 2013;73:296\u2013305.", "ArticleIdList": ["22887478"]}, {"Citation": "Xu M., Cui J., Fu H., Proksch P., Lin W., Li M. Embelin derivatives and their anticancer activity through microtubule disassembly. Planta Med. 2005;71:944\u2013948.", "ArticleIdList": ["16254827"]}, {"Citation": "Ahn K.S., Sethi G., Aggarwal B.B. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products. Mol Pharmacol. 2007;71:209\u2013219.", "ArticleIdList": ["17028156"]}, {"Citation": "Bailey J.M., Swanson B.J., Hamada T., Eggers J.P., Singh P.K., Caffery T. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res. 2008;14:5995\u20136004.", "ArticleIdList": ["PMC2782957", "18829478"]}, {"Citation": "Huang M., Tang S.N., Upadhyay G., Marsh J.L., Jackman C.P., Shankar S. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways. PLoS One. 2014;9 e92161.", "ArticleIdList": ["PMC3973629", "24694877"]}, {"Citation": "Chen J., Chen X., Lei Y., Wei H., Xiong C., Liu Y. Vascular protective potential of the total flavanol glycosides from Abacopteris penangiana via modulating nuclear transcription factor-kappaB signaling pathway and oxidative stress. J Ethnopharmacol. 2011;136:217\u2013223.", "ArticleIdList": ["21549824"]}, {"Citation": "Zhao Z., Ruan J., Jin J., Zou J., Zhou D., Fang W. Flavan-4-ol glycosides from the rhizomes of. Abacopteris penangiana. J Nat Prod. 2006;69:265\u2013268.", "ArticleIdList": ["16499328"]}, {"Citation": "Fang J.B., Chen J.C., Duan H.Q. Constituents from Abacopteris penangiana and their cytotoxicity activity. Chin Tradit Herb Drugs. 2010;10:1601\u20131604."}, {"Citation": "Tsang S.W., Zhang H.J., Chen Y.G., Auyeung K.K., Bian Z.X., Eruberin A. A natural flavanol glycoside, exerts anti-fibrotic action on pancreatic stellate cells. Cell Physiol Biochem. 2015;36:2433\u20132446.", "ArticleIdList": ["26279445"]}, {"Citation": "Bailey C.J. Metformin: historical overview. Diabetologia. 2017;60:1566\u20131576.", "ArticleIdList": ["28776081"]}, {"Citation": "Algire C., Amrein L., Zakikhani M., Panasci L., Pollak M. Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in\u00a0vivo and is associated with reduced expression of fatty acid synthase. Endocr Relat Cancer. 2010;17:351\u2013360.", "ArticleIdList": ["20228137"]}, {"Citation": "Gou S., Cui P., Li X., Shi P., Liu T., Wang C. Low concentrations of\u00a0metformin selectively inhibit CD133+ cell proliferation in pancreatic cancer and have anticancer action. PLoS One. 2013;8 e63969.", "ArticleIdList": ["PMC3648476", "23667692"]}, {"Citation": "Chae Y.K., Arya A., Malecek M.K., Shin D.S., Carneiro B., Chandra S. Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 2016;7:40767\u201340780.", "ArticleIdList": ["PMC5130043", "27004404"]}, {"Citation": "Song C.W., Lee H., Dings R.P., Williams B., Powers J., Santos T.D. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep. 2012;2:362.", "ArticleIdList": ["PMC3324825", "22500211"]}, {"Citation": "Duan W., Chen K., Jiang Z., Chen X., Sun L., Li J. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression. Cancer Lett. 2017;385:225\u2013233.", "ArticleIdList": ["27773749"]}, {"Citation": "Wu C., Qiu S., Zhu X., Lin H., Li L. OCT1-mediated metformin uptake regulates pancreatic stellate cell activity. Cell Physiol Biochem. 2018;47:1711\u20131720.", "ArticleIdList": ["29949790"]}, {"Citation": "Qian W., Li J., Chen K., Jiang Z., Cheng L., Zhou C. Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer. Life Sci. 2018;208:253\u2013261.", "ArticleIdList": ["30053447"]}, {"Citation": "Zechner D., Burtin F., Albert A.C., Zhang X., Kumstel S., Schonrogge M. Intratumoral heterogeneity of the therapeutical response to gemcitabine and metformin. Oncotarget. 2016;7:56395\u201356407.", "ArticleIdList": ["PMC5302922", "27486761"]}, {"Citation": "Gu L., Zhang H., Liu T., Draganov A., Yi S., Wang B. Inhibition of MDM2 by a rhein-derived compound AQ-101 suppresses cancer development in SCID mice. Mol Cancer Ther. 2018;17:497\u2013507.", "ArticleIdList": ["PMC6054458", "29282301"]}, {"Citation": "Kalyanaraman B., Cheng G., Hardy M., Ouari O., Sikora A., Zielonka J. Modified metformin as a more potent anticancer drug: mitochondrial inhibition, redox signaling, antiproliferative effects and future EPR studies. Cell Biochem Biophys. 2017;75:311\u2013317.", "ArticleIdList": ["PMC5680142", "28429253"]}, {"Citation": "Chen K.C., Juang S.H., Lien J.C. Identification of antiproliferative emodin analogues as inhibitors of epidermal growth factor receptor in cancer. Int J Mol Med. 2019;43:1281\u20131288.", "ArticleIdList": ["PMC6365047", "30664170"]}, {"Citation": "Viault G., Babu K.S., Gautier F., Barille-Nion S., Juin P., Tasseau O. Hemisynthesis of selected embelin analogs and investigation of their proapoptotic activity against cancer cells. Med Chem. 2013;9:1028\u20131034.", "ArticleIdList": ["23373598"]}, {"Citation": "Chatterjee A., Ronghe A., Padhye S.B., Spade D.A., Bhat N.K., Bhat H.K. Antioxidant activities of novel resveratrol analogs in breast cancer. J Biochem Mol Toxicol. 2018;32 e21925.", "ArticleIdList": ["28960787"]}, {"Citation": "Stadlbauer S., Steinborn C., Klemd A., Hattori F., Ohmori K., Suzuki K. Impact of green tea catechin ECG and its synthesized fluorinated analogue on prostate cancer cells and stimulated immunocompetent cells. Planta Med. 2018;84:813\u2013819.", "ArticleIdList": ["29466808"]}, {"Citation": "Poilil Surendran S., George Thomas R., Moon M.J., Jeong Y.Y. Nanoparticles for the treatment of liver fibrosis. Int J Nanomed. 2017;12:6997\u20137006.", "ArticleIdList": ["PMC5614791", "29033567"]}, {"Citation": "Sharma N., Bhandari S., Deshmukh R., Yadav A.K., Mishra N. Development and characterization of embelin-loaded nanolipid carriers for brain targeting. Artif Cells Nanomed Biotechnol. 2017;45:409\u2013413.", "ArticleIdList": ["27012597"]}, {"Citation": "Snima K.S., Jayakumar R., Lakshmanan V.K. In\u00a0vitro and in\u00a0vivo biological evaluation of O-carboxymethyl chitosan encapsulated metformin nanoparticles for pancreatic cancer therapy. Pharm Res. 2014;31:3361\u20133370.", "ArticleIdList": ["25115827"]}, {"Citation": "Wei Y., Wang Y., Xia D., Guo S., Wang F., Zhang X. Thermosensitive liposomal codelivery of HSA-paclitaxel and HSA-ellagic acid complexes for enhanced drug perfusion and efficacy against pancreatic cancer. ACS Appl Mater Interfaces. 2017;9:25138\u201325151.", "ArticleIdList": ["28696100"]}, {"Citation": "Yallapu M.M., Ebeling M.C., Khan S., Sundram V., Chauhan N., Gupta B.K. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013;12:1471\u20131480.", "ArticleIdList": ["PMC3965353", "23704793"]}]}], "History": [{"Year": "2019", "Month": "8", "Day": "3"}, {"Year": "2019", "Month": "9", "Day": "23"}, {"Year": "2019", "Month": "10", "Day": "29"}, {"Year": "2020", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "11", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32140388", "PMC7049637", "10.1016/j.apsb.2019.11.008", "S2211-3835(19)31076-7"]}}]}